Month: September 2024

VANCOUVER, British Columbia and HOLMDEL, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that its long-time customer, the province of British Columbia, has placed new orders with BIO-key. 10,000 users will be added to their existing deployment of WEB-key software, integrated with Broadcom’s SiteMinder infrastructure to streamline and strengthen access to a series of new applications via SAML 2.0 federation standards. BIO-key has worked closely with the province’s cybersecurity team to integrate BIO-key’s state-of-the-art, cloud-enabled biometric authentication...

GRAND JUNCTION, Colo., Sept. 23, 2024 (GLOBE NEWSWIRE) — ProStar Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), a global leader in Precision Mapping Solutions®, is proud to announce that a Global Fortune 500 Energy Company has adopted ProStar’s PointMan® solution to enhance maintenance and safety for refinery operations. The Company has implemented PointMan with an emphasis on precision mapping of the current infrastructure and assets for a refinery’s operations. This digital mapping initiative will lay the groundwork for future repair and maintenance of refinery projects, ensuring that older parts of the refinery’s infrastructure are systematically updated with precision. Once the updates are completed, PointMan will serve as the Geographic Information System (GIS) and data source, supporting...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Sept. 23, 2024 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the upcoming Planet MicroCap Showcase to be held September 25-26, 2024 in Vancouver. The conference will bring together the most promising companies and top dealmakers in microcap finance for two days of presentations, one-on-one meetings and educational panels. Mr. Dobbin will be presenting at the event by way of webcast on Wednesday, September 25, 2024 at 1:30 PM Eastern Time / (10:30 AM Pacific Time). The unique link allowing access to the Company’s webcast is: https://www.webcaster4.com/Webcast/Page/3056/51051 The...

Companies collaborating to learn how trailers of the future can best support autonomous truckingKodiak Selects Wabash’s Trailers as a ServiceKodiak Robotics, Inc., a leader in autonomous trucking technology, has partnered with Wabash (NYSE: WNC) to utilize Wabash’s Trailers as a Service (TaaS)℠ offering, providing a flexible solution with access to a growing fleet of safe, reliable trailers nationwide.LAFAYETTE, Ind., Sept. 23, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, logistics and distribution industries, is pleased to announce that Kodiak Robotics, Inc., a leading autonomous trucking company, has entered into a partnership with Wabash to utilize Wabash’s Trailers as a Service (TaaS)℠ offering. Wabash’s TaaS will provide Kodiak a flexible solution...

On track for 31 EH/s SYDNEY, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”) today provided a business update. “We are pleased to announce that we’ve reached our 20 EH/s milestone ahead of schedule. This achievement reflects the hard work of our global team. Thank you for your dedication and efforts in making this happen,” said Daniel Roberts, Co-Founder and Co-CEO of IREN. “We look forward to continuing this momentum as we expand to over 30 EH/s in the next three months.” IREN achieves 20 EH/s milestone IREN has increased its installed capacity to 20 EH/s (16 J/TH efficiency). Through optimization of its existing data center infrastructure, IREN now expects to increase its installed capacity to 21 EH/s in the coming days. On track for 31 EH/s in 4Q 2024 Childress...

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6 million in milestones MIPLYFFA™ is now the sixth commercial asset in XOMA Royalty’s portfolio EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today Zevra Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for MIPLYFFA™ (arimoclomol).  MIPLYFFA™ is approved for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients two years of age and older.  It is the sixth commercial asset in XOMA Royalty’s...